IP Library Granted Patent US 12,678,822
Granted Patent B2
US 12,678,822 · App. 18/608,317 · Granted Jul 14, 2026

Methods and systems for substrate functionalization

Inventors: William Schulkins (Campbell, CA); Angela Stern (Palo Alto, CA); Florian Oberstrass (Menlo Park, CA)
Assignee: Ultima Genomics, Inc.
B05D1/60B05D1/32B05D1/322C23C16/402C23C16/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,678,822
App. No.
18/608,317
Filed
Mar 18, 2024
Granted
Jul 14, 2026
Kind
B2
Art Unit
1712
USPC
427/255.6
Abstract

Provided herein are systems and methods for functionalizing a substrate. The method may comprise providing a substrate surface, wherein the substrate surface comprises a plurality of individually addressable locations, and exposing the substrate surface to a dose of organosilane vapor to generate a plurality of organosilane-functionalized locations on the substrate surface, wherein the plurality of organosilane-functionalized locations corresponds to at least a subset of the plurality of individually addressable locations. The dose of organosilane vapor may be provided at relatively low dose, in an example, at most about 1×10 24 molecules per m 2 .

Claims (17)

1 . A method of generating an organosilane-functionalized substrate, comprising:

(a) providing a substrate; and

(b) exposing said substrate to a plurality of doses of organosilane vapor to generate said organosilane-functionalized substrate, wherein a dose of said plurality of doses is at most 1×10 24 molecules per square meter (m 2 ) of a surface of said substrate wherein exposing said substrate to said plurality of doses of organosilane vapor provide a layer of organosilane functionalization with an average thickness of at least about 1.2 nanometers and a standard deviation of thickness measurements of at most about 1.0 nanometers.

2 . The method of claim 1 , wherein said plurality of doses comprises at most five doses.

3 . The method of claim 1 , wherein said plurality of doses comprises at least four doses.

4 . The method of claim 1 , wherein said dose of said plurality of doses is at least 1×10 20 molecules per m 2 of said surface of said substrate.

5 . The method of claim 1 , further comprising, (i) prior to (a) depositing a resist on said substrate; and (ii) subsequent to (b), removing said resist from said substrate to generate a patterned organosilane-functionalized substrate.

6 . The method of claim 1 , wherein in (b), said exposing is performed at a predetermined atmospheric pressure from about 5 millitorr (mTorr) to about 50 mTorr.

7 . The method of claim 6 , wherein said predetermined atmospheric pressure is about 25 mTorr.

8 . The method of claim 1 , further comprising immobilizing a bead comprising a nucleic acid molecule adjacent to said organosilane-functionalized substrate, wherein said nucleic acid molecule is coupled to the bead.

9 . The method of claim 8 , wherein said bead is immobilized to said organosilane-functionalized substrate via an electrostatic interaction between a positive charge of said organosilane-functionalized substrate and a negative charge of said bead or a constituent thereof.

10 . The method of claim 8 , further comprising immobilizing a plurality of beads to said organo-functionalized substrate, wherein an average bead diameter of said plurality of beads is at least about 0.5 microns.

11 . The method of claim 1 , wherein said organosilane-functionalized substrate comprises aminopropyltrimethoxysilane (APTMS).

12 . The method of claim 1 , wherein each dose of said plurality of doses is at most 1×10 24 molecules per m 2 of said surface of said substrate.

13 . The method of claim 1 , wherein said organosilane-functionalized substrate is patterned.

14 . The method of claim 1 , further comprising indexing a plurality of locations on said organosilane-functionalized substrate.

15 . The method of claim 14 , wherein said indexing comprises immobilizing a plurality of beads at said plurality of locations.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2026
From: ULTIMA GENOMICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 075435/0595 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2024
From: SCHULKINS, WILLIAM; STERN, ANGELA; OBERSTRASS, FLORIAN
To: ULTIMA GENOMICS, INC.
Reel/Frame 066846/0448 →
Continuity (3)
Continuation PCTUS2022044269 · Sep 21, 2022
Provisional Application 63247196 · Sep 22, 2021
Related Publication 20240326090A1 · Oct 3, 2024
References Cited (16)
US 5372851A · Ogawa · 1994 [cited by examiner]
US 5474796A · Brennan · 1995 [cited by examiner]
US 5688642A · Chrisey · 1997 [cited by examiner]
US 8765359B2 · Fernandez · 2014 [cited by examiner]
US 10512911B1 · Beckett et al. · 2019 [cited by applicant]
US 20050272268A1 · Hwang et al. · 2005 [cited by applicant]
US 20070128455A1 · Wolf · 2007 [cited by examiner]
US 20090270273A1 · Burns · 2009 [cited by examiner]
US 20100075034A1 · Kobrin · 2010 [cited by examiner]
US 20130323652A1 · Fernandez et al. · 2013 [cited by applicant]
US 20210079464A1 · Beckett et al. · 2021 [cited by applicant]
US 20230349893A1 · Didar · 2023 [cited by examiner]
WO WO2020118172A1 · 2020 [cited by applicant]
WO WO2020186243A1 · 2020 [cited by applicant]
WO WO2023049192A1 · 2023 [cited by applicant]
PCT/US2022/044269 International Search Report and Written Opinion dated Feb. 28, 2023. [cited by applicant]